November 12, 2026

Elite Diagnostic Limited (ELITE) has advised that on November 11, 2026, the Company received a revised Take-Over Bid Circular dated November 10, 2026, from the Offeror (the Updated Circular). ELITE has further advised that the Updated Circular replaces the prior Take-Over Bid Circular received by the Company on October 30, 2026. The principal changes are as follows:

• The consideration has been increased from J$1.60 to J$1.99 per share.
• The Offer will open on November 16, 2026, at 11:00 a.m. and close on December 21, 2026, at 4:00 p.m.

ELITE has also advised that the Board is reviewing the Updated Circular with its independent financial adviser and legal adviser. The Board’s Directors’ Circular, which will take account of the Updated Circular, will be published and sent to shareholders on or before Wednesday, November 18, 2026.

For further details, visit www.jamstockex.com

Analyst Certification -The views expressed in this research report accurately reflect the personal views of Mayberry Investments Limited Research Department about those issuer (s) or securities as at the date of this report. Each research analyst (s) also certify that no part of their compensation was, is, or will be, directly or indirectly, related to the specific recommendation(s) or view (s) expressed by that research analyst in this research report.

Company Disclosure -The information contained herein has been obtained from sources believed to be reliable, however its accuracy and completeness cannot be guaranteed. You are hereby notified that any disclosure, copying, distribution or taking any action in reliance on the contents of this information is strictly prohibited and may be unlawful. Mayberry may affect transactions or have positions in securities mentioned herein. In addition, employees of Mayberry may have positions and effect transactions in the securities mentioned herein.